Cyclopropanecarboxamidoximemonohydrochloride
CAS: 22926-85-8
Ref. 3D-FC149444
1g | A consultar | ||
2g | A consultar | ||
5g | A consultar | ||
10g | A consultar | ||
500mg | A consultar |
Informação sobre produto
- N'-hydroxycyclopropanecarboximidamide hydrochloride
- Cyclopropanecarboxamidoxime Monohydrochloride
Cyclopropanecarboxamidoxime hydrochloride (CPCA) is a diazine compound that is used as an anti-tuberculosis drug. It is the most potent of the diazine compounds for the treatment of tuberculosis. CPCA inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch-clamp technique on human erythrocytes. This active form is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. CPCA also specifically binds to markers expressed at high levels in Mycobacterium tuberculosis strains (e.g., ESX-1 secretion system protein) and inhibits cell growth in culture.
Propriedades químicas
Consulta técnica sobre: 3D-FC149444 Cyclopropanecarboxamidoximemonohydrochloride
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.